This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ionescu-Matiu, I., Kennedy, R. C., Sparrow, J. T., et al., 1983, Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol 130: 1947–52.
Relf, W. A., Cooper, J., Brandt, E. R., et al., 1996, Mapping a conserved conformational epitope from the M protein of group A streptococci. Pept Res 9: 12–20.
Mutter, M., Tuchscherer, G. G., Miller, C., et al., 1992, Template-assembled synthetic proteins with four-helix-bundle topology. J. Am. Chem. Soc. 114: 1463–1470.
Sutcliffe, J. G., Shinnick, T. M., Green, N., Liu, F. T., Niman, H. L., Lerner, R. A., 1980, Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature 287: 801–5.
Talwar, G. P., Sharma, N. C., Dubey, S. K.., et al., 1976, Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A 73: 218–22.
Fraser, H. M., Gunn, A., Jeffcoate, S. L., Holland, D. T., 1974, Effect of active immunization to luteinizing hormone releasing hormone on serum and pituitary gonadotrophins, testes and accessory sex organs in the male rat. J Endocrinol 63: 399–406.
Briand, J. P., Muller, S., Van Regonmortel, M. H. V., 1985, Synthetic peptides as antigens: pitfalls of conjugation methods. J. Immunol. Meth 78: 59.
Schutze, P. M., Leclerc, C., Jolivet, M., Audibert, F., Chedid, L., 1985, Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol 135: 2319–2322.
Francis, M. J., Hastings, G. Z., Syred, A. D., McGinn, B., Brown, F., Rowlands, D. J., 1987, Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 330: 168–70.
Borras-Cuesta, F., Fedon, Y., Petit-Camurdan, A., 1988, Enhancement of peptide immunogenicity by linear polymerization. Eur J Immunol 18: 199–202.
Dyrberg, T., Oldstone, M. B., 1986, Peptides as antigens. Importance of orientation. J Exp Med 164: 1344–9.
Etlinger, H. M., Knorr, R., 1991, Model using a peptide with carrier function for vaccination against different pathogens. Vaccine 9: 512–4.
Ghosh, S., Jackson, D. C., 1999, Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 11: 1103–1110.
Fitzmaurice, C. J., Brown, L. E., McInerney, T. L., Jackson, D. C., 1996, The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine 14: 553–60.
Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G., Lanzavecchia, A., 1989, Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19: 2237–42.
Sharma, P., Kumar, A., Batni, S., Chauhan, V. S., 1993, Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens. Vaccine 11: 1321–6.
Tam, J. P., 1988, Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A 85: 5409–13.
Hudecz, F., 1995, Design of synthetic branched-chain polypeptides as carriers for bioactive molecules. Anticancer Drugs 6: 171–93.
Butz, S., Rawer, S., Rapp, W., Birsner, U., 1994, Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides. Pept Res 7: 20–3.
Jackson, D. C., Fitzmaurice, C. J., Sheppard, R. C., McMurray, J., Brown, L. E., 1995, The antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers. Biomed Pep Prot and Nucl Acids 1: 171–176.
Brandt, E. R., Hayman, W. A., Currie, B., et al., 1996, Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 89: 331–7.
Rose, K., 1994, Facile synthesis of homogeneous artificial proteins. J. Am. Chem. Soc. 116:30–33.
Zeng, W., Rose, K.. and Jackson, D.C. Polyoximes: a flexible approach for producing homogeneous artificial proteins (1995). In: “Peptides 1994”, Proceedings of the Twenty-Third Peptide Symposium (September 4–10, 1994, Braga, Portugal). L.S. Maia, Ed. ESCOM, Leiden, The Netherlands 1995, pp 855–856.
Rose, K., Zeng, W., Brown, L. E., Jackson, D. C., 1995, A synthetic peptide-based polyoxime vaccine construct of high purity and activity. Mol Immunol 32: 1031–7.
Wilce, J. A., Zeng, W., Rose, K., Craik, D. J., Jackson, D. C., 1996, 1H NMR structural study of free and template-linked antigenic peptide representing the C-terminal region of the heavy chain of influenza virus hemagglutinin. Biomed Pept Proteins Nucleic Acids 2: 51–8.
O’Brien-Simpson, N. M., Ede, N. J., Brown, L. E., Swan, J., Jackson, D. C., 1997, Polymerisation of unprotected synthetic peptides: a view towards synthetic peptide vaccines. J. Am. Chem. Soc. 119: 1183–1188.
Jackson, D. C., O’Brien-Simpson, N., Ede, N. J., Brown, L. E., 1997, Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 15: 1697–705.
Wiesmuller, K. H., Bessler, W., Jung, G., 1983, Synthesis of themitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe Seylers Z Physiol Chem 364: 593–606.
Zeng, W., Jackson, D.C., Murray, J., Rose, K., and Brown, L.E. 1999, Totally synthetic lipid containing polyoxime peptide constructs are potent immunogens Vaccine in press.
Nardelli, B., Haser, P. B., Tam, J. P., 1994, Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses. Vaccine 12: 1335–9.
Deres, K., Schild, H., Wiesmuller, K. H., Jung, G., Rammensee, H. G., 1989, In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342: 561–4.
Melief, C. J., Offringa, R., Toes, R. E., and Kast, W. M. 1996, Peptide-based cancer vaccines. Curr Opin Immunol 8: 651–657.
Minev, B. R., Chavez, F. L., and Mitchell, M. S. 1998, New trends in the development of cancer vaccines. In Vivo 12: 629–638
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Jackson, D. et al. (2002). Synthetic Peptide and Their Polymers as Vaccomes. In: Chiellini, E., Sunamoto, J., Migliaresi, C., Ottenbrite, R.M., Cohn, D. (eds) Biomedical Polymers and Polymer Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/0-306-46842-5_23
Download citation
DOI: https://doi.org/10.1007/0-306-46842-5_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46472-0
Online ISBN: 978-0-306-46842-1
eBook Packages: Springer Book Archive